AstraZeneca (NASDAQ:AZN) shares gained in European trading on Thursday after the Anglo-Swedish drugmaker reported better-than-expected Q4 2024 results and addressed investor concerns over an ...
The European Central Bank (ECB) is hopeful that the recent support for dollar-pegged cryptocurrencies from U.S. President Donald Trump will speed up the legislative approval process for the digital ...
Revenues of $240.2 million in the fourth quarter of 2024 increased 25.3% compared to prior year period (increased 25.8% on a constant currency basis). Rates ADV was up 15.2% from prior year period, ...